We would like to invite you to the 2nd symposium of the BU’s Interdisciplinary Neuroscience Research Centre on Monday the 16th of January 2023 from 9:15-13:00 at the Create LT, Fusion Building (ground floor).
The symposium is entitled “New Frontiers in Neuroscience: Neuroimaging and Integrative Multi-Sensing Methods”. We will focus on these two themes from a cross-disciplinary angle, leveraging synergies between different departments at BU and our collaborators in industry, charities, and at the NHS. We think that this is a good opportunity to have informal discussions on grant proposals, also to explore shared interests with our external guests.
The schedule is:
9:15. Welcome and coffee.
9:30. Keynote talk by Prof. Mavi Sanchez-Vives, Biomedical Research Institute IDIBAPS, Barcelona. Human Brain Project Task Leader.
10.20-10:40. Coffee and grants discussion.
10:40-11:40. Session I. Neuroimaging and clinical applications.
11.40 -12.00. Coffee and grants discussion.
12.00-13:00. Session II. Integrating Multi-sensing approaches and industrial applications. Concluding remarks.
Thank you very much and we are looking forward to seeing you there. If you have any queries please do not hesitate to contact any of us (Ellen Seiss, eseiss@bournemouth.ac.uk or Emili Balaguer-Ballester eb-ballester@bournemouth.ac.uk).
Interdisciplinary Neuroscience Research Centre informal event










Deadline Approaching: Submit your Poster for the Research Conference by Monday 27 April
BU academics publish in Nepal national newspaper
New BU Physiology paper
Gender and street names
Help Shape the Future of Research at BU: Postgraduate Research Experience Survey 2026 Now Open
3C Event: Research Culture, Community & Cherry Blossom – Tuesday 14 April
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease